Method and system for radiotherapy planning
By using dose volume measurement as a constraint in the radiation therapy plan, the parameter set of radiation therapy plan is optimized, and the time-consuming and complex problems of the generation of treatment plan in the existing technology are solved, the rationality and efficiency of the treatment plan are improved, and many are met. Target dose requirements.
Patent Information
- Application Number
- CN202410577719.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-05-11
- Filing Date
- 2024-05-10
- Publication Date
- 2024-11-12
AI Technical Summary
In the generation of a radiotherapy plan, especially when multiple treatment plan goals exist, the prior art is time-consuming and complex, making it difficult to effectively optimize the dose distribution to meet the needs of each anatomical structure, resulting in the generated treatment plan being inappropriate.
By receiving the first and second reference targets, the parameter set is optimized to obtain a dose volume metric of the anatomical structure and as a constraint, the parameter set is further optimized to generate a radiotherapy plan to ensure the rationality and efficiency of the dose distribution.
Improved the generation efficiency and results of treatment plans, can more accurately meet the dose needs of anatomical structures, reduce damage to surrounding healthy tissues, and improve the clinical applicability of treatment plans.
Smart Images

Figure CN118925084A_ABST
Abstract
Description
Technical Field
[0001] Embodiments herein relate to methods and systems for radiation therapy planning. Background Art
[0002] Radiation therapy or radiotherapy can be described as the use of ionizing radiation to damage or destroy unhealthy cells in humans and animals. Ionizing radiation can be directed to tumors on the surface of the skin or deep inside the body. Common forms of ionizing radiation include X-rays and charged particles. An example of a radiation therapy technique is called a Gamma Knife. ) or Leksell Gamma ), where a patient is irradiated with multiple lower intensity gamma rays that are focused at a target area (e.g., a tumor) with higher intensity and precision. Another example of radiation therapy includes the use of a linear accelerator (linac), whereby a target area is irradiated with high energy particles (e.g., electrons, high energy photons, etc.). In another example, radiation therapy is provided using heavy charged particle accelerators (e.g., protons, carbon ions, etc.).
[0003] The placement and dosage of radiation beams are accurately controlled to deliver a prescribed radiation dose to a target area (e.g., a tumor) and reduce damage to surrounding healthy tissue (called organs at risk or OARs). A "tumor" may refer to a cancerous tumor, a "target" may refer to a cancerous target, and a "target area" may refer to an area that includes a cancerous target.
[0004] One aspect of treatment planning involves determining suitable characteristics of the radiation to be delivered to produce a safe and effective dose. The characteristics of the radiation relate to, for example, the fluence pattern. The fluence pattern may depend on beam arrangement, energy, and field size, which in turn are related to controllable parameters (which are optimizable). By determining suitable values for these parameters, a suitable fluence pattern may be obtained. The treatment plan may be determined by a treatment planning system.
[0005] Generating a radiation therapy plan (treatment plan) includes using an optimization process to determine the optimal set of parameters that will deliver an appropriate dose. The optimization process can be based on clinical and dosimetric goals and constraints. Examples of clinical and dosimetric goals and constraints include maximum, minimum, and mean doses to tumors and critical organs. Clinical and dosimetric goals and constraints can be referred to as treatment plan objectives.
[0006] The treatment planning process can include using a three-dimensional image of the patient to identify the target area and identify critical organs near the tumor. Segmentation can be used to identify the target area, the area to be treated (e.g., planned target volume (PTV)), and the organ at risk (OAR). After segmentation, a dose plan can be created for the patient, which indicates the desired amount of radiation to be received by the PTV (e.g., target) and / or OAR. The PTV can have an irregular volume.
[0007] In a practical example, there may be multiple anatomical structures (i.e., PTV, target, and / or OAR). For example, in head and neck treatment, there may be more than 20 anatomical structures. For each structure, it is desired to meet various treatment plan goals. Different priorities can be assigned to the structures and their goals in order to achieve a clinically acceptable plan. Determining a treatment plan that meets the various goals is time consuming and complex.
[0008] There is a need for improved methods and systems for generating treatment plans. Summary of the invention
[0009] As described above, the generation of treatment plans can be time consuming and complex, especially when there are many treatment planning goals.
[0010] Treatment planning includes performing an optimization process that optimizes multiple parameters with the goal of providing a sufficiently high dose to the PTV while reducing the dose to surrounding healthy tissue. A clinically appropriate plan can be obtained by balancing different treatment planning goals, for example by prioritizing treatment planning goals related to dose coverage at the PTV and then prioritizing treatment planning goals related to protecting OARs. By prioritizing one goal over another, it means that an optimization process is performed based on a first goal and then another optimization process is performed based on a second goal having a lower priority than the first goal. It should be understood that throughout the present invention, the term optimization and its variations can be used interchangeably.
[0011] A user (e.g., a treatment planner, dosimetrist, clinician, or healthcare worker) can implement a clinically appropriate plan as follows. For each treatment plan objective, the user can configure the optimizer by defining, for example, a reference dose, a reference volume, and / or a cost function. An example of a treatment plan objective can be stated as "97% of the PTV volume should receive at least 40 Gy." This objective represents the goal to be achieved. The optimizer will then attempt to find the optimization parameters that meet the goal. The solution found by the optimizer may or may not meet the desired goal (based on the anatomical structure, the limitations of the radiotherapy machine, and / or the difficulty of the problem). Based on the achieved goal, the optimization can be repeated using the revised goal to be achieved. This method is time-consuming and results in variable results based on the user's selection of the revised goal to be achieved. In addition, when multiple treatment plan objectives are considered, the method is repeated for each objective, making plan generation more time-consuming.
[0012] Some treatment planning objectives relate to the dose to be delivered to the volume of the anatomical structure. Such treatment planning objectives can be defined in terms of dose values (reference dose) and volume values (reference volume). Reference dose and reference volume are single values. They do not correspond to spatial dose distributions over the entire volume. Optimization of treatment planning objectives can use those single reference doses and reference volumes (rather than dose distributions). Optimization may not produce the desired results, especially when there are multiple treatment planning objectives.
[0013] The methods and systems herein address a technical problem arising in the field of radiation therapy planning, namely, how to improve the generation of treatment plans. In particular, when the treatment plan goal relates to the dose to be delivered to a volume of an anatomical structure, the methods and systems relate to improving the results of the optimization process (and therefore the suitability of the optimization parameters in the generation of the treatment plan).
[0014] This is achieved by performing an optimization according to a first treatment planning objective (first reference objective) to determine a dose-volume metric for the anatomical structure. The dose-volume metric is then taken into account in a subsequent optimization based on another treatment planning objective (second reference objective). In particular, the dose-volume metric is used as a constraint in the subsequent optimization. By using the above as a constraint, the results of the optimization process can be improved.
[0015] A dose volume metric includes a dose value and a corresponding volume value. A dose volume metric can be obtained from a dose distribution in an anatomical structure. A dose volume metric is related to how much of a given dose an anatomical structure receives and / or what dose a given volume of an anatomical structure will receive. An example of a dose volume metric is "52 Gy at 85% volume". For example, a dose volume metric can be (i) what dose a prescribed volume of an anatomical structure will receive (achieved dose at a reference volume), and / or (ii) what volume of an anatomical structure will receive a prescribed dose (achieved volume at a reference dose).
[0016] According to a first aspect, a method for radiotherapy planning for a radiotherapy system is provided, the method comprising:
[0017] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system, and the first reference target comprising a reference dose to be delivered to a reference volume of the anatomical structure;
[0018] Optimizing a set of parameters related to characteristics of radiation to be delivered by the radiotherapy system based on the received first reference target and the received second reference target, wherein the optimized set of parameters comprises:
[0019] optimizing the set of parameters based on the first reference objective to obtain a dose-volume metric for the anatomical structure; and
[0020] further optimizing the set of parameters based on a second reference objective using the dose volume metric as a constraint; and
[0021] A radiation therapy plan was generated using the further optimized parameter sets.
[0022] The generated radiation therapy plan may be used by the radiation therapy system for the delivery of radiation therapy.The generated treatment plan may be output for use in delivering radiation by the radiation therapy system.
[0023] In one example, the dose volume metric includes a dose at a corresponding volume of the anatomical structure.In one embodiment, the dose volume metric includes an achieved dose at a volume between 70% and 100% of a reference volume and / or an achieved volume at a dose between 80% and 120% of a reference dose.
[0024] In one embodiment, the dose volume metric comprises an achieved dose at a reference volume and / or an achieved volume at a reference dose.
[0025] In some embodiments, optimizing the parameter set includes, in response to the dose-volume metric not satisfying the first reference objective, further optimizing the parameter set based on a second reference objective using the dose-volume metric as a constraint.
[0026] The dose-volume metric (e.g., achieved dose at a reference volume and / or achieved volume at a reference dose) may not meet the first reference target (including the reference dose at the reference volume) for several reasons. For example, the first reference target may be too stringent and / or other pre-existing constraints may limit the solution space, making it impossible to find a parameter set that will meet the target.
[0027] In some embodiments, optimizing the parameter set includes: in response to the achieved dose at the reference volume or the achieved volume at the reference dose not satisfying the first reference target, modifying the achieved dose at the reference volume to obtain a relaxation dose, and further optimizing the parameter set based on the second reference target using the relaxation dose at the reference volume and the achieved volume at the reference dose as constraints.
[0028] The relaxation dose is a dose value that is less limiting than the achieved dose. Using the relaxation dose instead of the achieved dose provides the optimizer with "more room" for subsequent optimization steps.
[0029] In some embodiments, obtaining a dose volume metric from the optimized parameter set includes obtaining a dose distribution in the anatomical structure using the optimized parameter set, and obtaining a dose volume metric from the dose distribution. For example, the dose volume metric is a dose X Gy to be received by Y% of the anatomical structure.
[0030] In some embodiments, the dose distribution is represented by a dose volume histogram DVH.
[0031] In some embodiments, the first reference target comprises any one of the following cost functions: a target penalty cost function; an underdose DVH cost function, an overdose DVH cost function, and a parallel cost function.
[0032] According to some examples, the second reference target includes the same cost function as the first reference target. For example, when the first reference target includes a target penalty cost function, the second reference target includes a second target penalty cost function. Alternatively, the second reference target includes a different cost function than the first reference target.
[0033] In some embodiments, the optimization parameter set includes:
[0034] optimizing the set of parameters based on the first reference objective to obtain a dose-volume metric; and
[0035] further optimizing the parameter set using the dose-volume metric as a target to obtain an intermediate parameter set;
[0036] The intermediate parameter set is further optimized based on the second reference target and using the dose volume metric as a constraint to obtain a further optimized parameter set.
[0037] In some embodiments, wherein the dose-volume metric comprises an achieved volume at a reference dose and / or an achieved dose at a reference volume, and wherein further optimizing the parameter set using the dose-volume metric as a target comprises using a weighted sum of a first cost function based on the achieved volume at the reference dose and a second cost function based on the achieved dose at the reference volume.
[0038] Performing further optimization using the dose volume metric as a target further improves the results of the optimization process.
[0039] According to another aspect, a method for radiation therapy planning for a radiation therapy system is provided, the method comprising:
[0040] receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system, and the reference target comprising a reference dose to be delivered to a reference volume of the anatomical structure;
[0041] Optimizing a set of parameters according to the received reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein the optimized set of parameters comprises:
[0042] optimizing a set of parameters based on a reference target to obtain a dose-volume metric; and
[0043] further optimizing the set of parameters based on the received reference target and an additional target, the additional target being based on a dose-volume metric;
[0044] A radiation therapy plan was generated using the further optimized parameter sets.
[0045] The dose volume metric obtained after the optimization (e.g. it can be the achieved dose at the reference volume and / or the achieved volume at the reference dose) is taken into account in the further optimization. In particular, the dose volume metric is used together with the received reference target as a further target in the further optimization. By using the further target, the result of the optimization can be improved.
[0046] In some examples, further optimizing the set of parameters based on the received reference objective and using the additional objective based on the dose-volume metric includes using a weighted sum of a cost function for the received reference objective and a cost function based on the dose-volume metric.
[0047] According to another aspect, there is provided a treatment planning system comprising a processor configured to:
[0048] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system, and the first reference target comprising a reference dose to be delivered to a reference volume of the anatomical structure;
[0049] Optimizing a set of parameters related to characteristics of radiation to be delivered by the radiotherapy system based on the received first reference target and the received second reference target, wherein the optimized set of parameters comprises:
[0050] optimizing the set of parameters based on the first reference objective to obtain a dose-volume metric; and
[0051] further optimizing the set of parameters based on a second reference objective using the dose volume metric as a constraint; and
[0052] A radiation therapy plan was generated using the further optimized parameter sets.
[0053] According to another aspect, there is provided a radiation therapy planning system comprising a processor configured to:
[0054] receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system, the reference target comprising a reference dose to be delivered to a reference volume of the anatomical structure;
[0055] Optimizing a set of parameters according to the received reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein the optimized set of parameters comprises:
[0056] optimizing a set of parameters based on a reference target to obtain a dose-volume metric; and
[0057] further optimizing the parameter set based on the received reference target and an additional target based on the dose-volume metric;
[0058] A radiation therapy plan was generated using the further optimized parameter sets.
[0059] In an embodiment, the treatment planning system comprises a processor configured to perform any of the methods described above.
[0060] In an embodiment, the method is a method for radiation therapy planning for delivering radiation therapy by a radiation therapy system.
[0061] According to another aspect, there is provided a computer-readable medium comprising computer-executable instructions configured to cause a processor to perform any of the above methods.
[0062] The methods are computer-implemented methods. Since some methods according to the examples may be implemented by software, some examples encompass computer code provided to a general purpose computer on any suitable carrier medium. The carrier medium may include any storage medium (e.g., a floppy disk, CD ROM, magnetic device, or programmable storage device) or any transient medium (e.g., any signal, such as an electrical, optical, or microwave signal). The carrier medium may include a non-transient computer-readable storage medium. BRIEF DESCRIPTION OF THE DRAWINGS
[0063] Systems and methods according to non-limiting examples will now be described with reference to the accompanying drawings, in which:
[0064] Figure 1A A block diagram of an optimization process according to an example is shown;
[0065] Figure 1BA block diagram of an optimization process applied to IMRT according to an example is shown;
[0066] Figure 2 A flow chart showing a method of radiation therapy planning according to an embodiment;
[0067] Figure 3 A flow chart showing a method of radiation therapy planning according to an embodiment;
[0068] Figure 4 An example of a dose volume histogram (DVH) for a target is shown;
[0069] Figure 5 An example of a dose volume histogram (DVH) for an OAR is shown;
[0070] Figure 6 shows a schematic diagram of a radiation therapy system according to an embodiment;
[0071] Figure 7 A schematic diagram showing a computer readable medium according to an embodiment; and
[0072] Figure 8 A radiation therapy device or apparatus is shown. DETAILED DESCRIPTION
[0073] Figure 1A A block diagram of an optimization process 100 is shown. The optimization process 100 is applicable to the optimization of a parameter set (i.e., one or more parameters) of a radiation therapy system. The one or more parameters may be referred to as optimizable parameters or decision variables. Examples of optimizable parameters include parameters related to characteristics of radiation to be delivered by the radiation therapy system. For example, the parameter set relates to a flux map. The flux map may also be referred to as an intensity distribution map. The flux map may correspond to weights for beamlets (beamlets are described below). An example of a radiation therapy system will be described below.
[0074] The optimization module 100 includes an optimizer 107. Given a model 101 and one or more parameters 103, the purpose of the optimizer 107 is to provide an optimized set of parameters 111 that minimizes the cost function 102. The optimizer includes at least one optimization algorithm, such as a simplex algorithm, a gradient-based algorithm, an interior point algorithm, and the like, and combinations thereof. Other optimization algorithms are also possible. The optimization algorithm may be executed until a stopping criterion is reached. For example, the stopping condition may be any one or more of the following conditions: reaching the number of iterations, satisfying the convergence criteria, and violating a constraint (such as the constraint 105 described herein). The constraint may be a predetermined constraint defined before performing the optimization process. Examples of predetermined constraints are the clinical and planning constraints shown in rows a to l of Table 1. Alternatively, the constraints may be obtained from a previous optimization process. An example of optimization is shown in FIG. The optimization process may correspond to the optimization process described in European patent application publication EP3681600A1, for example.
[0075] The model 101 is a representation of the physical problem. For radiation therapy planning, the model 101 includes, for example, a dose distribution over voxels in a region. The dose distribution can be the dose at a unit integral flux. The region can correspond to an anatomical structure. The anatomical structure can include one or more of the following structures: a target, a healthy tissue region (called an organ at risk or OAR), a planning target volume (PTV), a critical structure, or a shell structure. These structures are determined and / or defined during a process called segmentation. Shell structures are structures that are generated to adjust the dose delivered to tissue surrounding the target, and they can be used to control dose conformality. The dose distribution can be determined by a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. Additional details on how the dose can be determined are described in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.
[0076] The one or more parameters 103 are optimizable parameters (also referred to as decision variables) for which the optimizer 107 attempts to find optimal values. The one or more parameters 103 may be initialized to predetermined values. In one example, for IMRT, when the parameters 103 are weights of beamlets, the parameters 103 may be initialized to predetermined weights. Alternatively, the parameters 103 may be initialized to values determined in a previous step. For example, when performing further optimization, the parameters may be initialized to values determined in a previous optimization.
[0077] The beam can be divided into beamlets, where the weight of each beamlet can be adjusted. A beam can be understood as a beamlet matrix. Therefore, a beam can be represented by a number of beamlets. The total dose distribution is then the weighted sum of the contributions of the individual beamlets at unit flux (e.g., the dose at voxel k is given by ∑x n ·d n,k Given, where n is the index of beamlet n, x n is the weight of beamlet n, and d n,k is the dose at unit flux at voxel k due to beamlet n). By adjusting the weights of the beamlets, the radiation can be modulated. The weights of the beamlets can be adjusted by adjusting the configuration of the beam shaping device (e.g. Figure 8850). For example, when the beam shaping device is an MLC, an optimized beamlet weight (and therefore a desired dose distribution) can be achieved by using different aperture shapes (also called segments) of the MLC to shape the delivered radiation. The weight of the beamlet is related to the dose rate. The dose rate refers to how much dose a linear accelerator or energy source can deliver per unit time. For a fixed dose rate, the beamlet weight is proportional to the amount of time the beamlet is active. For example, a higher weight means that the beamlet remains active for a longer time. Therefore, the weight of the beamlet is a function of the dose rate and / or the duration that the beamlet remains active.
[0078] The cost function 102 is a mathematical formula that relates the parameters 103 and the model 101. The cost function may be referred to as an objective function. The cost function 102 relates the dose distribution in the model 101 to a single value (the cost function value 109). For example, when the reference target is "the average dose to the bladder is less than 30 Gy", the cost function mathematically formulates and calculates the average dose to the bladder based on the parameters 103, and compares the achieved average dose to the reference 30 Gy. During optimization, the optimizer 107 looks for parameters that will minimize the difference between the achieved average dose and the reference average dose. The cost function value quantifies how close the dose in the model is to the expected value.
[0079] The cost function value 109 is the value of the cost function when evaluated using the optimization parameter set. The cost function value 109 is calculated by the optimizer during optimization. The cost function value 109 can be called a penalty. Optionally, the cost function value 109 is output by the optimizer.
[0080] The cost function value 109 defines the penalty for violating the objective or constraint. The optimizer evaluates this penalty during optimization. Optionally, in constrained optimization, only the objective contributes to the cost function.
[0081] The constraints 105 include one or more conditions that the optimization parameters 111 must satisfy. Constraints can be hard constraints (which set conditions that the parameters need to satisfy) or soft constraints (which have some variable values that are penalized in the cost function when some conditions are not met). Constraints limit the set of solutions that can be obtained. Constraints are used to define what is physically or clinically acceptable, rather than mathematically possible. For example, for IMRT, a constraint may be that the weights of the beamlets must be non-negative (because negative beamlet weights are impossible). Note that constraints 105 are optional features. Additionally and optionally, constraints 105 include an indication of one or more cost functions 102 to be used. Also optionally, the constraints include an indication of the anatomical structure to which the constraints apply. When constraints 105 are used with cost functions 102, the constraints are satisfied when the difference between the cost function value and the cost function evaluated at the constraint value is less than a predetermined amount.
[0082] The reference target 104 represents a target to be achieved. In one example, for IMRT, the reference target includes a dose-based target and / or a volume-based target. A dose target can be defined based on a dose value (in Gy). An example of a dose target can be stated as "the average dose to the OAR should be less than or equal to 30 Gy." A volume-based target can include a relative volume or an absolute volume. A relative volume represents a fraction of a volume. For example, a relative volume is a percentage. An absolute volume can be based on a physical size (e.g., in mm, cm, mm 3 、cm 3 The reference target 104 may be defined as a volume-based target (in units of, for example, y Gy). An example of a volume-based target may be stated as "at least 90% of the volume of the PTV should receive the prescribed dose". In another example, the reference target 104 may be stated as "at least X% of the first region receives at least Y Gy". The optimizer 107 may then determine optimization parameters 111 that result in an achieved target value 113 that is close to the reference target 104. The reference target may be referred to as a treatment planning target. Note that the reference target 104 is an optional feature. Additionally and optionally, the reference target 104 includes an indication of one or more cost functions 102 to be used. Also optionally, the reference target includes an indication of the anatomical structure for which the target to be achieved applies.
[0083] Reference targets are anatomically specific functions that establish dose and / or bioresponse targets. Constraints 105 are anatomically specific functions that must be satisfied. They may be referred to as hard constraints. When constraints are used with targets, the constraints are always satisfied, while the targets may not be satisfied (instead, they are goals that the optimizer attempts to achieve).
[0084] The cost function 102 together with the model 101, parameters 103, constraints 105 (optional) and reference target 104 (optional) define the problem to be solved.
[0085] The cost function 102, the constraint 105, and the reference target 104, alone or in any combination, may be referred to as a treatment planning goal. The treatment planning goal may be associated with an anatomical structure. In other words, the treatment planning goal may include any one of the cost function 102, the constraint 105, and the reference target 104. An example of a treatment planning goal may be stated as "97% of the PTV volume should receive a dose of at least 30 Gy using the "target penalty" cost function." Other examples of treatment planning goals are listed in rows m to x in Table 1 below.
[0086] The optimizer 107 aims to find an optimized set of parameters 111 for which the cost function 102 is minimized. The optimized parameters 111 are the output of the optimizer 107. In one example, when there is a reference target 104, the optimizer 107 minimizes the difference between the target value 113 and the reference target 104.
[0087] Optionally, the optimizer 107 outputs a cost function value 109. The cost function value 109 is the value of the cost function 102 when evaluated using the optimization parameters 111.
[0088] Optionally, the optimizer 107 outputs an achieved target value 113. The achieved target value 113 is comparable to the reference target. The achieved target value 113 represents a value having the same unit as a given reference target. The achieved value 113 may be different from the cost function value 109. Unlike the cost function value 109, which may be a number evaluated as a cost function, the achieved value 113 may have a physical meaning. In one example, when the reference target includes a dosimetry target in units of gray (Gy), the achieved target value also relates to the dose (i.e., it has the unit Gy and / or the same physical meaning as the reference target). In one example, when the reference target includes a reference volume and a dose value, the achieved target value also relates to the reference volume and the dose value (i.e., it has the same physical meaning as the reference target). As will be described below with respect to Table 1, the reference target may be based on DVH and may be a percentage of a volume for receiving a predetermined dose. The cost function value 109 may be a number corresponding to a cost function evaluated using an optimized parameter set. The achieved target value 113 will be the achieved percentage of a volume for receiving a predetermined dose. In other words, the achieved target value 113 is comparable to the reference target.
[0089] Figure 1B An example of a two-stage optimization process 150 for IMRT is shown. The optimization process may also be applied to volumetric modulated radiation therapy (VMAT). Although this example applies to IMRT, note that the optimization process 100 may be applied to other radiation therapy modalities.
[0090] In IMRT, one or more radiation beams are directed to the tumor. The intensity of the individual beam profiles is non-uniform. The purpose of the optimization process 150 is to modify the intensity profile so that a sufficiently high dose is delivered to the tumor while reducing the dose delivered to healthy organs.
[0091] The optimization method of IMRT 150 includes two stages. The first stage 151 is the flux map optimization (FMO) and the second stage 153 is to determine the configuration of the radiation therapy system. In FMO (stage 151), the optimal flux map is determined. Then, the optimal flux map is used to determine the configuration of the radiation therapy system in stage 2. The FMO step 151 will be described next. Step 153 will be further described below.
[0092] For flux optimization, each beam is divided into a plurality of beamlets. Then, the contribution of each beamlet to the voxel at unit flux is calculated. Initially, the beamlets may be equally weighted and may contribute equally to the dose distribution. During optimization, the weights of each beamlet are adjusted so that the cost function is minimized. By multiplying the weight by the contribution of each beamlet at unit flux and then summing all beamlets, the full dose distribution may be obtained. The full dose distribution may be compared with any constraints and / or reference targets to determine whether the optimized solution is appropriate.
[0093] The optimization process of FMO can also be expressed as follows: The optimization process of FMO can be performed by the optimization process 100 described herein.
[0094] Optimization consists in minimizing a cost function f(x) by determining appropriate values of the parameters x based on certain constraints g. For FMO, the parameters x correspond to the weights of the beamlets (x may also be referred to as decision variables, which are parameters that can be controlled). The output of FMO (stage 151) includes the parameters x.
[0095] The constraints g include limits. Examples of limits are a minimum dose at a voxel corresponding to a target, or a maximum dose at a voxel corresponding to an OAR, and so on.
[0096] In one example, the cost function f(x) is:
[0097] f(x)=T1+T2+...+T3
[0098] Among them, for example, T1 = ∑x n .d n , where x corresponds to the weight of the beamlet, d n It represents the dose delivered to a voxel by each beamlet at unit intensity. n is a non-optimizable parameter (e.g. it may depend on the machine configuration and / or the characteristics of the organization). n can be obtained from the above model 101. For example, from the model 101, it is known whether the voxel n belongs to the target, OAR, etc. In one example, the dose d n It can be determined by a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. Optionally, the dose calculation uses a pencil beam algorithm or a convolution-based algorithm (which is fast but has reduced accuracy). How the dose d can be determined n Additional details are in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.
[0099] The output of Phase 1 may include dose distribution.
[0100] In this example, the objective function f(x) is the sum of the total doses (T1, T2 ... T3), where each of T1, T2 ... T3 represents the dose on a different structure. Note that alternative formulations of the problem to be solved may be used (e.g., by defining different cost functions or constraints).
[0101] In one example, a requirement for the dose at the target to be above a certain amount can be formulated as a constraint. Alternatively, such a requirement can be formulated as a reference target.
[0102] Step 151 provides an optimized set of parameters (e.g., beamlet weights x) that will provide an optimal intensity map (or flux map). In preparation for delivery by a radiotherapy system, a further step (step 153) is required to convert the individual optimized beamlet weights into a configuration of the machine that will deliver the optimal flux.
[0103] Next, the determination of the configuration (step 153) is described.
[0104] In step 153, the output from step 151 is converted into a configuration of a radiotherapy system. The configuration can be used by a radiotherapy device (examples of which are described herein) to deliver radiotherapy. For example, the configuration of the radiotherapy system includes a collection of aperture configurations (i.e., one or more aperture configurations). The shapes and weights of the aperture configurations are selected to meet the same goals as in the first stage. Here, the shape refers to the shape of the opening. The individual shapes can be referred to as segments. Here, the weights refer to the weights of the individual segments. The weights of the segments are related to the dose rate. For a fixed dose rate, the segment weight is proportional to the amount of time the beam is delivered through the segment. For example, a higher segment weight means a longer delivery time through the segment. Therefore, the weight of the segment is a function of the dose rate and / or the duration that the beam is delivered through the segment. The aperture configuration can be determined by a beam shaping device (e.g. Figure 8 When the beam shaping device is an MLC, the shape is defined by the leaf positions.
[0105] The aperture configuration may be referred to as control points or segments. The control points and / or segments include radiation information (eg, energy, dose) and geometric information (eg, gantry angle and leaf position).
[0106] The shape and weights of the apertures may be determined by applying algebraic and trigonometric considerations to the arrangement of the apertures in order to achieve the optimized beamlet weights of step 151 .
[0107] Alternatively, step 153 includes performing a second stage optimization process to determine an optimized aperture configuration that will achieve the optimized fluence pattern determined in step 151. The second stage optimization process may be referred to as aperture optimization or aperture refinement.
[0108] Aperture optimization can include the following:
[0109] - Receive a set of beamlet weights (eg, from step 151).
[0110] - Perform an optimization to determine the optimized aperture shape and optionally weights. The optimization can be performed using e.g. Figure 1B Other optimization procedures are also possible.
[0111] When the beam shaping device includes an MLC, aperture optimization may include:
[0112] - Receiving a set of beamlet weights from a FMO and / or a flux profile (eg from step 151 ).
[0113] - Convert the received profile into beamlet widths (openings between leaf pairs). This produces segments.
[0114] - Optimize the weights of the resulting segments.
[0115] - Optionally, optimizing the shapes of the generated segments (using a process known as segment shape optimization).
[0116] Note that the optimization step in step 153 may include calculation of a dose distribution. The dose distribution may be calculated using a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. Optionally, the dose calculation in step 153 uses an MC-based algorithm (which is more accurate but computationally expensive).
[0117] Additional details on aperture optimization are given in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.
[0118] Notice, Figure 1B The process involves a specific angle. In one approach, a previous step would be to determine the angle from which the radiation is delivered. Figure 1B The Beam Angle Optimization (BAO) process is performed before the process. Then, for each determined angle, Figure 1B process.
[0119] Although Figure 1B The example of relates to a two-stage optimization process for IMRT (FMO of step 151 and configuration determination of step 153), but note that alternative optimization methods such as direct machine parameter optimization (DMPO) may be used instead. In DMPO, the decision variables x correspond to parameters of the machine delivering radiation (e.g., MLC leaf positions). Alternatively again, the decision variables x may correspond to any one or more of the following: number of beams, beam angles, dose per beam, beamlet weights, segment or control point shapes, segment or control point weights, dose volume histogram information, dose excess values.
[0120] Returning to the cost function 102 in the optimization process 100, examples of cost functions include: target EUD, target penalty, secondary overdose, secondary underdose, continuous, parallel, maximum dose, overdose DVH, underdose DVH. The cost function is briefly defined below. Each cost function provides a different calculation method.
[0121] When the cost function includes any of target penalty, parallelism, overdose DVH, and underdose DVH, the reference target is a dose value and a relative volume component (eg, percentage) or an absolute volume (eg, in cc).
[0122] When the cost function includes any of target EUD, secondary overdose, continuous, maximum dose, or conformality, the reference target is the dose value.
[0123] Cost functions such as sequential, parallel, quadratic overdose, overdose DVH or maximum dose are intended to limit the dose at the anatomical structure. For example, for these cost functions, the penalty increases when the achieved dose exceeds the reference dose. The higher the achieved dose is above the reference dose, the more the penalty increases.
[0124] Cost functions such as secondary underdose or underdose DVH aim to increase the dose at the anatomical structure. Cost functions such as target EUD and target penalty aim to increase the dose at the structure. For example, these cost functions are for the target or PTV, and the penalty increases when the achieved dose is below the reference dose. The lower the achieved dose is below the reference dose, the more the penalty increases.
[0125] Some of the above cost functions also take unitless numbers as input. The unitless numbers are power law exponents.
[0126] The target EUD cost function defines the structure as the target volume and expresses the probability of target cells surviving at a given dose. The cost function requires a specified dose as input (i.e., the reference target of the cost function is the dose value). The specified dose in Gy is the equivalent uniform dose (EUD). EUD is a uniform dose that, if delivered at the anatomical structure, has the same clinical effect as a non-uniform dose distribution.
[0127] The target penalty cost function takes a prescribed dose as input. A minimum volume is also provided as input (i.e., the reference target of the cost function is dose and relative volume). The target penalty is a quadratic penalty that starts with a threshold dose. It produces a steeper dose gradient after the target threshold is met. The target penalty is used to define the requirement that at least some portion of the total anatomical volume should receive at least the target dose. For example, the target penalty is defined as:
[0128]
[0129] where V is the total volume of the associated anatomical structure, V i is the volume occupancy of voxel i, Δ is the prescribed dose (reference dose), D i is the dose at voxel i. [.]- 2 The operator implies a one-sided penalty (i.e., the cost function value is considered only when the voxel dose < the reference dose). For example, if the threshold dose (reference dose) is 70 Gy, and if the voxel dose is 75 Gy, then the term “[.] 2 -" is zero (because the voxel dose is above the reference dose), but if the voxel dose is 65 Gy, then the term "[.] 2 -” is (65-70)^2=25.
[0130] Note that although the mathematical expression of the target penalty cost function shown in the above example does not include a reference volume, the reference volume is provided by the user. The volume that receives the prescribed dose Δ is determined from the dose distribution.
[0131] For example, when a target penalty is used as the objective (and the optimizer's goal is to minimize the cost function value), with a reference dose of 70 Gy, the optimizer will try to push all voxel doses above 70 Gy. If the result is that all voxel doses are indeed above 70 Gy, the final cost function value is 0, and the volume is 100% (because all voxel doses exceed the threshold dose of 70 Gy). If only 80% of the voxel doses exceed the threshold dose, the volume is 80%. When a target penalty cost function is used as the objective, a weighting factor that depends on the reference volume can be assigned to the cost function. For example, if the reference volume is 90%, the internal weighting factor is "a"; if the reference volume is 100%, the internal weighting factor is "b", where "b" is much larger than "a". If the reference volume is 100%, this will make the optimizer "work harder".
[0132] The quadratic dose overdose (QO) cost function is a cost function used to limit the dose in the structure to which the dose is applied. QO can be applied to the target or OAR. The QO cost function can be used to limit hot spots in the target. The QO cost function takes as input the maximum dose and the root mean square (RMS) dose overdose (i.e., the reference target includes two dose values). The maximum dose defines the dose above which a penalty occurs. The RMS dose overdose defines the acceptable amount of violation.
[0133] The quadratic underdose cost function is a cost function applied to the target volume. The quadratic underdose function implements a quadratic penalty. The cost function takes as input the minimum dose in Gy and the dose deficit in Gy (i.e., the reference target includes two dose values). The minimum dose is the minimum dose allowable in the target and represents the dose below which the penalty occurs. The dose deficit is similar to the RMS dose overdose in that it defines the amount of acceptable prescription violation.
[0134] The continuous cost function is often used with continuous OARs. Continuous anatomical structures are structures where high doses are harmful even if they are confined to a small volume. Examples include the spinal cord and intestine. This cost function imposes a large penalty on hot spots even if they are small in volume. The cost function takes as input the EUD in Gy and a power law exponent k (i.e., the reference target includes both the dose value and the unitless number).
[0135] Parallel cost functions are often used for parallel OARs. Parallel structures are structures that tolerate very high doses in a small volume while the rest of the organ is protected. Examples are lungs, parotid glands, kidneys, liver. The cost function takes as input a reference dose in Gy, an average organ damage (which is the fraction of the volume of the structure that can be sacrificed), and a power law exponent p (i.e., the reference target includes a dose value, a relative volume, and a unitless number). The parallel cost function can be called a partial volume (PV) cost function. Note that the parallel cost function can also be used for targets to prevent too high a dose on the target.
[0136] For example, the parallel cost function can be defined as:
[0137]
[0138] where ζ is the reference volume (%) (also called mean organ damage (%)), V is the total volume of the associated anatomical structure, and V i is the volume occupancy of voxel i, Δ is the prescribed dose (reference dose), D i is the dose at voxel i.
[0139] The maximum dose cost function is effectively a hard barrier that can be applied to target structures or OARs. The maximum dose cost function has a penalty that takes effect whenever a voxel crosses a maximum dose threshold. The cost function takes as input the maximum dose in Gy (ie, the reference target includes the dose value).
[0140] The overdose DVH cost function takes as input a target dose in Gy and a maximum volume (i.e., a reference target includes a dose value and a relative volume). This cost function can be applied to OARs, and / or it can also be applied to targets (e.g., to prevent overdose). The goal is to keep volumes that receive more than the target dose below the relative volume.
[0141] For example, the overdose DVH (ODVH) can be defined as:
[0142] ODVH(D;V,△,do)≤《
[0143]
[0144]
[0145] where ζ is the maximum volume (reference volume), V is the total volume of the associated anatomical structure, and V i is the volume occupancy of voxel i, Δ is the prescribed dose (reference dose), D i is the dose at voxel i, and for example d0=0.04Δ.
[0146] The underdose DVH cost function takes as input a target dose in Gy and a minimum volume (i.e., a reference target includes a dose value and a relative volume). The cost function is applied to the target. The goal is to keep the target volume that receives less than the target dose above the minimum volume.
[0147] For example, underdose DVH (UDVH) (b) can be defined as:
[0148] UDVH(D;V,△,d0)≤(1-)
[0149]
[0150]
[0151] where ζ is the minimum volume (reference volume), V is the total volume of the associated anatomical structure, and V i is the volume occupancy of voxel i, Δ is the prescribed dose (reference dose), D i is the dose at voxel i, and in one example, d0=0.04Δ.
[0152] Additional details of the cost function are given in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.
[0153] Figure 2 A flow chart of a method for radiotherapy treatment planning according to an embodiment is shown. The method generates a radiotherapy treatment plan that can be performed by a radiotherapy system (e.g. Figure 6 The radiation therapy system 600 is used to implement a treatment plan for radiation therapy. Figure 2 The method can be obtained by Figure 6 The treatment planning system 610 is described as performing.
[0154] At step 201, a first reference target and a second reference target are received. Each reference target represents a goal to be achieved when delivering radiation through a radiation therapy system. Optionally, the target is a clinical goal specified by a user (eg, a physician). The reference targets correspond to reference targets 104 described herein.
[0155] The first reference target includes a reference dose to be delivered to a reference volume of the anatomical structure. The reference dose is a dose value and has units such as Gy. The reference volume is a volumetric amount and can be in units such as mm, cm, mm 3 、cm 3 An absolute amount in units of , cc, etc., or a relative amount defined as a fraction or percentage of the volume of the anatomical structure. An example of a first reference target is 60 Gy at 99.5% volume of the target.
[0156] For example, when the anatomical structure is the target, it is expected that the entire structure receives a prescribed dose (reference dose). In other words, it is expected that 100% of the structure receives the prescribed dose. In practice, this may not be possible, and a reference volume is provided to indicate an acceptable volume of the structure that should receive the prescribed dose (reference dose). For example, the reference volume may be 90%, 95%, or 99.5%. When the anatomical structure is an OAR, it is expected that the OAR receives as little dose as possible. For example, it may be expected that 90% of the structure receives less than the prescribed dose.
[0157] In step 203, optimization is performed to optimize a set of parameters (i.e., one or more parameters). The optimization is performed based on the first reference target and the second reference target received in step 201. The purpose of the optimization is to find parameter values that will achieve the received reference targets. Step 203 includes steps 2031 and 2033. Optionally, in steps 201 and / or 203, one or more cost functions used with each reference target during optimization are received. One or more cost functions may be provided by a user. For example, the cost function includes any one or more of the following functions: a target penalty cost function, an underdose DVH cost function, an overdose DVH cost function, and a parallel cost function.
[0158] In step 2031, a parameter set is optimized according to a first reference target, and a dose volume metric is obtained. For example, the dose volume metric can be the achieved dose at the reference volume and / or the achieved volume at the reference dose. An example of a dose volume metric is that 80% of the structure receives 50 Gy. For example, the optimization of step 2031 can be performed by Figure 1A The optimization process 100 described in .
[0159] In more detail, in the optimization of step 2031, the optimization algorithm is executed until a stop condition is met. For example, the stop condition can be any one or more of the following conditions: reaching the number of iterations, satisfying the convergence criteria, and violating the constraints. The constraints can be predetermined constraints defined before performing the optimization process. Examples of predetermined constraints are the clinical and planning constraints shown in rows a to l of Table 1. Alternatively, the constraints can be obtained from a previous optimization process. After the optimization stops, the optimized parameter set is obtained. The achieved target value, cost function value and / or dose distribution can also be obtained. From the output of the optimization process, a dose volume metric can be obtained. For example, the dose volume metric can be obtained from the dose distribution.
[0160] At step 2033, further optimization is performed according to the second reference target and using the dose volume metric as a constraint. For example, the optimization of step 2033 may be performed by Figure 1A The optimization process 100 described in . The optimization of step 2033 is similar to the optimization of step 2031, except that the optimizer uses constraints derived from the dose-volume metric to seek to satisfy the second reference target. For example, when the dose-volume metric obtained in step 2031 is "80% of the structure receives 50 Gy", then in step 2033, the optimization process is constrained to find parameters such that the condition "80% of the structure receives 50 Gy" is satisfied. Additionally and optionally, the constraints based on the dose-volume metric include the same cost function as for the first reference target. The constraints may involve the same anatomical structure as the first reference target. Alternatively, the constraints are based on a different cost function than the first reference target. Still alternatively, the constraints involve different anatomical structures than the first reference target.
[0161] Using the dose volume metrics from step 2031 as constraints in step 2033 may be understood as automatically adding constraints for step 2033. No user input is required.
[0162] With respect to step 203 , when the dose volume metric is obtained (at step 2031 ), it is then used as a constraint in step 2033 .
[0163] The result of step 2033 is a further optimized parameter set. Achievement target values, cost function values and / or dose distributions will also be obtained.
[0164] At step 204, a treatment plan is generated using the further optimized parameter set. The treatment plan of step 204 may be used for the delivery of radiation therapy. The treatment plan includes a further optimized parameter set related to the characteristics of the radiation to be delivered by the radiation therapy system. For example, step 204 may correspond to Figure 1B Step 153 of the description.
[0165] Additionally and optionally, the dose volume metric may be a dose to be received by a prescribed volume of the anatomical structure (achieved dose at a reference volume) and / or a volume of the anatomical structure that will receive the reference dose (achieved volume at a reference dose). With respect to step 203, when the achieved dose at the reference volume is obtained (at step 2031), then the achieved dose at the reference volume is used as a constraint in step 2033. Similarly, when the achieved volume at the reference dose is obtained (at step 2031), then the achieved volume at the reference dose is used as a constraint in step 2033. When both the achieved dose at the reference volume and the achieved volume at the reference dose are obtained in step 2031, either or both may be used as constraints in step 2033.
[0166] Additionally and optionally, the second reference target comprises a reference dose to be delivered to the reference volume. Alternatively, the second reference target may comprise only the reference dose. Also optionally, the second reference target may relate to the same anatomical structure as the first reference target, or alternatively to a different anatomical structure.
[0167] Additionally and optionally, at step 2031, a dose distribution is obtained. The dose distribution is obtained using the optimized parameters from step 2031. From the dose distribution, a dose volume metric can be derived. Optionally, from the dose distribution, a dose volume histogram (DVH) can be derived. The dose distribution can be represented by the DVH. The dose volume histogram DVH relates the radiation dose to the volume of the anatomical structure. The DVH is a 2D representation of the three-dimensional dose distribution. Optionally, the dose volume metric is derived from the DVH.
[0168] Additionally and optionally, when step 2031 includes deriving a dose of a reference volume to be delivered to the anatomical structure (achieved dose at the reference volume) and an achieved volume at the reference dose, in step 2033, further optimization is performed according to a second reference target using the achieved dose at the reference volume and the achieved volume at the reference dose as constraints.
[0169] Additionally and optionally, when the dose volume metric includes an achieved volume at a reference dose, step 2033 is performed in response to the achieved volume at the reference dose not meeting the first reference target. By not meeting the reference target, it is meant that the achieved volume at the reference dose deviates from the first reference target by a predetermined amount. In particular, this means that the achieved dose at the reference volume deviates from the reference dose by a predetermined amount, or the achieved volume deviates from the reference volume by a predetermined amount, or both. Also optionally, in response to the achieved volume at the reference dose meeting the first reference target, step 2033 includes performing further optimization according to a second reference target; however, the achieved volume at the reference dose is not used as a constraint. The achieved dose at the reference volume is also not used as a constraint.
[0170] In addition and optionally, with respect to step 2033, in response to the achieved dose under the reference volume or the achieved volume under the reference dose not meeting the first reference target, the achieved dose under the reference volume is modified to obtain a relaxation dose, and the relaxation dose under the reference volume is used as a constraint in further optimization. Optionally, the achieved volume under the reference dose is used together with the relaxation dose under the reference volume as a constraint. By modifying the achieved dose to obtain a relaxation dose, it is meant to modify the achieved dose using a predetermined value (relaxation value). By modification, for example, it is meant to perform an operation including any one of multiplication, division, addition or subtraction between the achieved dose and the relaxation value to obtain the relaxation dose. The relaxation dose may not be as strict as the achieved dose under the reference volume. For example, the relaxation dose may be farther from the first reference target than the achieved dose under the reference volume.
[0171] Additionally and optionally, the first reference target includes any of the following cost functions: a target penalty cost function; an underdose DVH cost function, an overdose DVH cost function, and a parallel cost function. As described herein, the reference target may include a cost function. For example, the first reference target may be that at least a portion of the anatomical structure achieves a prescribed dose, wherein any deviation from the prescribed dose is penalized according to the cost function. During optimization, the cost function is minimized, and therefore the deviation of the achieved dose from the prescribed dose is also minimized. For example, the first reference target may be that 99.5% of the PTV (reference volume) receives 60 Gy (reference dose), and the target penalty cost function is minimized during optimization.
[0172] Additionally and optionally, the constraints used in step 2033 include the same cost function as the first reference target. A constraint can have an associated cost function. For example, when the first reference target is to achieve a dose of 60 Gy in 99.5% of the target volume using a target penalty cost function, the constraint can be that 99.5% of the anatomical volume receives 52 Gy using a target penalty cost function. A constraint is a condition that the optimizer must satisfy. The constraint is satisfied when the target penalty cost function evaluated with the dose at the reference volume differs by less than a predetermined amount from the target penalty cost function evaluated at 52 Gy and the 99.5% volume (reference volume).
[0173] Note that the second reference target may relate to the same or different anatomical structures. The second reference target has a lower priority than the first target. The second reference target may include the same or different cost functions. Further optimization is performed based on the second reference target using the achieved volume at the reference dose (which has been obtained during the previous optimization based on the first reference target) as a constraint.
[0174] Additionally and optionally, with respect to step 203, the optimization process includes optimizing a parameter set based on a first reference target (which includes a reference dose and a reference volume of an anatomical structure) to obtain (i) an achieved dose at a reference volume and / or (ii) an achieved volume at a reference dose. Then, further optimization is performed using (i) the achieved dose at a reference volume and / or (ii) the achieved volume at a reference dose as one or more targets to obtain an intermediate parameter set. The further optimization may involve the same anatomical structure as the initial optimization. Further optimization using (i) the achieved dose at a reference volume and / or (ii) the achieved volume at a reference dose as targets may provide an improved parameter set (intermediate parameter set) compared to the initial optimization based on the reference dose at the reference volume. The intermediate parameter set is further optimized based on a second reference target and using (ii) the achieved volume at a reference dose as a constraint to obtain a further optimized parameter set. Note that each optimization is performed until a stop criterion is met, as described with respect to step 2031. Optionally, further optimization based on (i) the achieved dose at a reference volume and / or (ii) the achieved volume at a reference dose as one or more targets to obtain an intermediate parameter set is based on the same cost function as the initial optimization according to the reference target.
[0175] Note that, optionally, when the parameter set is further optimized using the achieved volume under the reference dose and the achieved dose under the reference volume as the target, the cost function may include a weighted sum of a first cost function based on the achieved volume under the reference dose and a second cost function based on the achieved dose under the reference volume. For example, the cost function F may be: F(d ref ,v ref ,d ach ,v ach ,x)=w1f1(d ref ,v ach ,x)+w2f2(d ach ,v ref ,x), where x represents the optimizable parameter, d ref is the reference dose, v ref is the reference volume, d ach is the realized dose at the reference volume, v ach is the volume that will receive the reference dose, w1 is the weight assigned to the first cost function f1, and w2 is the weight assigned to the second cost function f2. w1 and w2 may be equal or different.
[0176] Example scenario - Next we describe Figure 2Example of a scenario. In one example, the first reference target is to achieve a dose of 60 Gy in 99.5% of the target volume. After optimizing according to the first reference target (step 2031), it is determined to achieve a dose of 52 Gy in 99.5% of the volume (the achieved dose at the reference volume). It is also found that 80% of the target volume will receive a reference dose of 60 Gy (the achieved volume at the reference dose). Then further optimization is performed according to the second reference target using 60 Gy in 80% of the target volume (the achieved volume at the reference dose) as a constraint (step 2033). A further optimized set of parameters is obtained, and a treatment plan is generated from these parameters. Further optimization (step 2033) can use a dose of 52 Gy in 99.5% of the volume (the achieved dose in the reference volume) as an alternative to the achieved volume at the reference dose or as an additional constraint.
[0177] Note that the second reference target may relate to the same or a different anatomical structure. The second reference target may relate to a different treatment plan target altogether.
[0178] Figure 3 A flow chart of a method for radiotherapy treatment planning according to an embodiment is shown. The method generates a radiotherapy treatment plan that can be performed by a radiotherapy system (e.g. Figure 6 The radiation therapy system 600 is used to implement a treatment plan for radiation therapy. Figure 3 The method can be obtained by Figure 6 The treatment planning system 610 is described as performing.
[0179] In step 301, a reference target is received. The reference target represents a target to be achieved when delivering radiation through a radiation therapy system. Optionally, the target is a clinical target specified by a user (e.g., a physician). The reference target corresponds to reference target 104 described herein. The reference target corresponds to the target of Figure 2 The first reference target of the description.
[0180] In step 303, optimization is performed to optimize a set of parameters (i.e., one or more parameters). The optimization is performed according to the reference target received in step 301. The purpose of the optimization is to find parameter values that will achieve the received reference target. Step 303 includes steps 3031 and 3033. Optionally, in steps 301 and / or 303, a cost function is received for use with the reference target during optimization. The cost function may be provided by a user.
[0181] Step 3031 is similar to step 2031, except that a reference target is used instead of the first reference target. The result of step 3031 is a dose volume metric.
[0182] In step 3033, further optimization is performed based on the reference target and using an additional target based on the dose volume metric. The further optimization using the additional target may provide an improved set of parameters (a further optimized set of parameters) compared to the initial optimization based only on the reference target. Note that each optimization is performed until a stopping criterion is met, as described with respect to step 2031.
[0183] In step 304, a treatment plan is generated using the further optimized parameter set from step 303. Step 304 corresponds to Figure 2 Step 204.
[0184] Additionally and alternatively, the dose volume metric may be the dose to be received by a specified volume of the anatomy (achieved dose at reference volume) and / or the volume of the anatomy that will receive a reference dose (achieved volume at reference dose).
[0185] Additionally and optionally, the further optimization of step 3033 uses a cost function comprising a weighted sum of the reference objective and the further objective. For example, the cost function F may be: F(d ref ,v ref ,d ach ,v ach ,x)=w1F ref (d ref ,v ref ,x)+w2F further (d ach ,v ref ,x), where x represents the optimizable parameter, d ref is the reference dose, v ref is the reference volume, d ach is the realized dose at the reference volume, v ach is the volume that will receive the reference dose, w1 is the volume allocated to the reference target F ref The weight w2 is assigned to another target F further weights. w1 and w2 can be equal or different.
[0186] Additionally and optionally, the further objective comprises the same cost function as the reference objective.
[0187] Additionally and optionally, step 3033 is performed in response to the achieved dose at the reference volume or the achieved volume at the reference dose not meeting the reference target. By not meeting the reference target, it is meant that the achieved dose at the reference volume or the achieved volume at the reference dose deviates from the reference target by a predetermined amount. In particular, this means that the achieved dose at the reference volume deviates from the reference dose, or the achieved volume at the reference dose deviates from the reference volume by a predetermined amount. Also optionally, in response to the achieved dose at the reference volume and / or the achieved volume at the reference dose meeting the reference target, step 3033 is omitted. In step 304, a treatment plan is generated using the optimized parameter set from step 3031 (rather than the further optimized parameter set from step 3033).
[0188] Additionally and optionally, with respect to step 3033, in response to the achieved dose at the reference volume and / or the achieved volume at the reference dose not meeting the reference target, modifying the achieved dose at the reference volume to obtain a relaxation dose. The additional target of step 3033 is based on the relaxation dose at the reference volume. Optionally, the additional target is based on the achieved volume at the reference dose and the relaxation dose at the reference volume. Modifying the achieved dose to obtain a relaxation dose has the same meaning as with respect to Figure 2 Same meaning as described.
[0189] Example scenario - Next we describe Figure 3 Example of a scenario. In one example, the reference target is to achieve a dose of 60 Gy in 99.5% of the target volume. After optimizing according to the reference target (step 3031), it is determined to achieve a dose of 52 Gy in 99.5% of the volume (the achieved dose at the reference volume). It is also found that 80% of the target volume will receive a reference dose of 60 Gy (the achieved volume at the reference dose). Further optimization is then performed according to the reference target and additional targets based on 52 Gy in 99.5% of the volume (the achieved dose at the reference volume) and / or 60 Gy in 80% of the target volume (the achieved volume at the reference dose) (step 3033). A further optimized set of parameters is obtained, and a treatment plan is generated from these parameters.
[0190] Figure 4 A diagram of a dose volume histogram (DVH) 400 for a target is shown. As described herein, the DVH relates radiation dose to the volume of an anatomical structure. The DVH can be used to evaluate and compare generated treatment plans. The vertical axis represents the fraction of the volume of the anatomical structure (the target in this figure) and is expressed as a percentage. The horizontal axis represents the dose. Figure 4 In FIG. 4 , the horizontal axis is normalized to the prescribed dose (reference target) and is shown as a percentage (however, absolute units of Gy may also be used). DVH 400 shows two curves 402 and 403. Curves 402 and 403 refer to the Figure 2The first reference goal is to obtain a dose of 60 Gy in 99.5% of the target volume. The second reference goal may relate to a different treatment planning goal. For example, the second reference goal may relate to keeping the dose in the OAR to a minimum. Therefore, there may be a trade-off between satisfying the first reference goal that seeks to increase the dose in the target and satisfying the second reference goal that seeks to reduce the dose in the OAR.
[0191] In an ideal scenario, the DVH curve for the target would be square (ie, 100% of the volume would achieve 100% of the prescribed dose of 60 Gy).
[0192] Curve 402 (shown by a dashed line ---) represents a comparative example in which the optimization is performed as follows. A first optimization process is performed according to a first reference target, and then a second optimization is performed according to a second reference target. Curve 402 is located to the left of 100% dose (i.e., 60 Gy) in 100% target volume. This indicates that no portion of the target volume will receive a reference dose of 60 Gy (i.e., 100% on the horizontal axis).
[0193] Curve 403 (shown by dotted line . . . ) relates to the use of Figure 2 A portion of the curve is to the right of 100% dose (ie, 60 Gy) in 100% target volume, indicating that at least a portion of the target volume will receive the prescribed dose. The result represented by curve 403 may be more desirable than the result depicted by curve 402.
[0194] Portion 404 represents the dose that will be received by 99.5% of the target volume (i.e., the achieved dose at the reference volume). Portion 406 represents the volume that will receive 100% of the prescribed dose of 60 Gy (i.e., the achieved volume at the reference dose). Figure 2 In the example scenario depicted, point 404 corresponds to 52 Gy in the 99.5% target volume, while point 406 corresponds to 60 Gy in the 80% target volume. By using point 406 (and alternatively or additionally point 404) as constraints in the optimization according to the second reference objective, the optimizer is pushed to find a solution that satisfies these constraints. This can lead to a more desirable treatment plan (e.g., Figure 4 exemplified by curve 403 in FIG.
[0195] Curve 403 may also involve using Figure 3 In this case, the additional objective based on point 406 (and optionally 404) influences the optimizer to move toward a solution that can satisfy the additional objective.
[0196] Figure 5 FIG. 4 shows a diagram of a dose volume histogram (DVH) 400B for an OAR. The DVH 400B is similar to Figure 4DVH 400, except that it relates to OARs, where the goal is to reduce the dose received by the OARs. Curves 402B and 403B correspond to curves 402 and 403, respectively. In DVH 400B, 100% dose on the horizontal axis represents the upper limit of the dose to be delivered. Points 404B and 406B correspond to Figure 4 The curve 402B is located to the right of the 100% volume point and the 100% dose (undesirable), while at least a portion of the curve 403B is located to the left of the 100% volume point and the 100% dose.
[0197] In more detail, curve 402B (shown by a dashed line ---) represents a comparative example of performing optimization as follows. A first optimization process is performed according to a first reference target (where the goal is to reduce the dose to the OAR), and then a second optimization is performed according to a second reference target (where the goal may be to increase the dose at different structures). Curve 402B is located to the right of 100% dose at approximately 100% of the target volume. This indicates that a large portion of the volume of the OAR will receive an excessive dose.
[0198] Curve 403B (shown by dotted line ···) relates to the use of Figure 2 A portion of the curve is to the left of 100% dose (ie, below the upper dose limit) for some volumes of the anatomical structure. Curve 403B may be more desirable than curve 402B.
[0199] Next, an example of a wish list will be described with reference to Table 1. The wish list represents a clinical prescription. The clinical prescription can be defined by a user and defines what is expected to be achieved. The wish list includes one or more goals. Here, the goal corresponds to the reference goal 104, 201 or 301 described herein. Alternatively (not shown in Table 1), the goal can be formulated as a constraint instead. The constraint refers to the constraint 105 described herein.
[0200] An example of a portion of a wish list for radiation therapy for prostate cancer is described below.
[0201] Table 1: Example of a wish list
[0202]
[0203]
[0204] The expectation list shown in Table 1 includes the following.
[0205] The wish list includes "clinical" constraints (rows a to f). Violation of these constraints means plan rejection. The wish list also includes "planning" constraints (rows g to l). The purpose of "planning" constraints is to achieve dose conformality and control potential hot spots.
[0206] Clinical constraints and planning constraints are predefined constraints. For example, Figure 4 Step 407 may refer to checking whether such clinical constraints are met. The purpose of the constraints in rows a to l is to limit the dose at the corresponding structure.
[0207] In Table 1, the structure name represents the anatomical structure. The structure is obtained by a process called segmentation, in which contours are drawn on slices of MRI images or CT images to identify different structures. The contours can be generated manually (e.g., by a physician, dosimetrist, or health worker) or automatically using atlas-based automatic segmentation software.
[0208] The wish list also includes prioritized targets (rows m to x). The prioritized targets correspond to the reference targets described herein. The prioritized targets include targets related to dose coverage and conformality of the target (which are the 1st priority targets in rows m to q) and targets related to dose protection of OARs (rows r to y). The prioritized targets can be user defined priorities.
[0209] In Table 1, "Cost Function (Parameter Values)" relates to the type of cost function to be used. For some cost functions, additional parameters are provided. "Target" refers to the dose or volume to be achieved by the treatment planning system.
[0210] For example, in row m, the reference target is 97% of the urethral PRV (a) to achieve a dose of 33.2 Gy. The cost function associated with the reference target is the "target penalty".
[0211] For each structure, one or more cost functions and associated objectives are defined, each achieving a different purpose. For example, at rows r to t, for the "rectum" structure, different cost functions and objectives are applied.
[0212] In Table 1, the priority refers to the relative priority of the referenced objectives. In Table 1, the objectives related to dose coverage and conformality of the target (which are the 1st priority objectives in rows m to q) are optimized first, and then the objectives related to dose protection of OARs (rows r to y) are optimized, in the order of their priorities.
[0213] In Table 1, the hierarchical order refers to the volume of overlapping structures. When structures include overlapping voxels, the structure with the higher hierarchical order "owns" the voxel.
[0214] Further examples of wish lists are provided in Naccarato, S., Rigo, M., Pellegrini, R., Voet, P., Akhiat, H., Gurrera, D., De Simone, A., Sicignano, G., Mazzola, R., Figlia, V. and Ricchetti, F., 2022. Automated planning for prostate stereotactic body radiation therapy on the 1.5T MR-Linac. Advances in radiation oncology, 7(3), p.100865.
[0215] Figure 6 A block diagram of an implementation of a radiation therapy system 600 is illustrated. The radiation therapy system 600 includes a computing system 610 within which a set of instructions for causing the computing system 610 to perform any one or more of the methods discussed herein may be executed. The computing system 610 may implement a treatment planning system. The computing system 610 may also be referred to as a computer. The treatment planning system 610 may perform any of the methods described herein. In particular, the methods described herein may be implemented by a processor 611 of the treatment planning system 610.
[0216] Computing system 610 should be considered to include any number of machines or machine collections, such as one or more computing devices, which individually or jointly execute one or more instruction sets to perform any one or more methods discussed herein. That is, hardware and / or software can be provided in a single computing device, or distributed on multiple computing devices in a computing system. In some implementations, one or more elements of a computing system can be connected (e.g., networked) to other machines in, for example, a local area network (LAN), an intranet, an extranet, or the Internet. One or more elements of a computing system can operate with the ability of a server or client machine in a client-server network environment, or operate as a peer machine in a peer-to-peer (or distributed) network environment. One or more elements of a computing system can be a personal computer (PC), a tablet computer, a set-top box (STB), a personal digital assistant (PDA), a cellular phone, a network appliance, a server, a network router, a switch or a bridge, or any machine capable of executing a set of instructions (sequential or otherwise), which specifies the action to be taken by the machine.
[0217] The computing system 610 includes a controller circuit 611 and a memory 613 (e.g., a read-only memory (ROM), a flash memory, a dynamic random access memory (DRAM) such as a synchronous DRAM (SDRAM) or a Rambus DRAM (RDRAM), etc.). The memory 613 may include a static memory (e.g., a flash memory, a static random access memory (SRAM), etc.) and / or an auxiliary memory (e.g., a data storage device), which communicate with each other via a bus (not shown).
[0218] Controller circuit 611 represents one or more general-purpose processors, such as microprocessors, central processing units, accelerated processing units, etc. More particularly, controller circuit 611 may include complex instruction set computing (CISC) microprocessors, reduced instruction set computing (RISC) microprocessors, very long instruction words (VLIW) microprocessors, processors implementing other instruction sets, or processors implementing a combination of instruction sets. Controller circuit 611 may also include one or more special processing devices, such as application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), digital signal processors (DSPs), network processors, etc. One or more processors of the controller circuit may have a multi-core design. Controller circuit 611 is configured to execute processing logic for executing the operations and steps discussed herein.
[0219] The computing system 610 may also include a network interface circuit 618. The computing system 610 may be communicatively coupled to an input device 620 and / or an output device 630 via an input / output circuit 617. In some implementations, the input device 620 and / or the output device 630 may be elements of the computing system 610. The input device 620 may include an alphanumeric input device (e.g., a keyboard or a touch screen), a cursor control device (e.g., a mouse or a touch screen), an audio device such as a microphone, and / or a tactile input device. The output device 630 may include an audio device such as a speaker, a video display unit (e.g., a liquid crystal display (LCD) or a cathode ray tube (CRT)), and / or a tactile output device. In some implementations, the input device 620 and the output device 630 may be provided as a single device or separate devices.
[0220] In some implementations, the computing system 610 may include an image processing circuit 619. The image processing circuit 619 may be configured to process image data 680 (e.g., images or imaging data), such as medical images obtained from one or more imaging data sources, treatment devices 650, and / or image acquisition devices 640. The image processing circuit 619 may be configured to process or pre-process the image data. For example, the image processing circuit 619 may convert the received image data into a specific format, size, resolution, etc. In some implementations, the image processing circuit 619 may be combined with the controller circuit 611.
[0221] In some implementations, the radiation therapy system 600 may also include an image acquisition device 640 and / or a treatment device 650, such as described herein. Figure 8 The device disclosed in the example of . The image acquisition device 640 and the treatment device 650 can be provided as a single device. In some implementations, the treatment device 650 is configured to perform imaging, for example in addition to providing treatment and / or during treatment. The treatment device 650 includes the main radiation delivery components of the radiation treatment system, such as the beam shaping device 850.
[0222] The image acquisition device 640 may be configured to perform positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), single positron emission computed tomography (SPECT), X-ray, and the like.
[0223] Image acquisition device 640 may be configured to output image data 680 that may be accessed by computing system 610. Treatment device 650 may be configured to output treatment data 660 that may be accessed by computing system 610.
[0224] The computing system 610 may be configured to access or obtain treatment data 660, planning data 670, and / or image data 680. The treatment data 660 may be obtained from an internal data source (e.g., from the memory 613) or from an external data source (e.g., the treatment device 650 or an external database). The planning data 670 may be obtained from the memory 613 and / or from an external source such as a planning database. The planning data 670 may include information obtained from one or more of the image acquisition device 640 and the treatment device 650.
[0225] The above methods may be implemented by a computer program. The computer program may include computer code (eg, instructions) 710, which is arranged to instruct a computer to perform the functions of one or more of the above methods. Figure 2 and Figure 3 The steps of the method described above may be performed by computer code 710. The steps of the method described above may be performed in any suitable order. Figure 8The computer program and / or code 710 for performing this method is provided to a device such as a computer on one or more computer readable media described in or more generally on a computer program product 700. The computer readable medium may be transient or non-transient. The one or more computer readable media 700 may be, for example, an electronic, magnetic, optical, electromagnetic, infrared or semiconductor system, or a propagation medium for data transmission (e.g., for downloading code via the Internet). Alternatively, the one or more computer readable media may take the form of one or more physical computer readable media, such as semiconductor or solid-state memory, magnetic tape, removable computer disk, random access memory (RAM), read-only memory (ROM), hard disk and optical disk (e.g., CD-ROM, CD-R / W or DVD). The instructions 710 may also reside completely or at least partially in the memory 613 and / or in the controller circuit 611 during its execution by the computer system 610, the memory 613 and the controller circuit 611 also constituting computer readable storage media.
[0226] In implementation, the modules, components, and other features described herein may be implemented as discrete components, or integrated into the functionality of hardware components such as ASICs, FPGAs, DSPs, or similar devices.
[0227] A "hardware component" is a tangible (e.g., non-transient) physical component (e.g., a set of one or more processors) that is capable of performing certain operations and may be configured or arranged in some physical manner. A hardware component may include dedicated circuitry or logic that is permanently configured to perform certain operations. A hardware component may include a dedicated processor, such as an FPGA or ASIC. A hardware component may also include programmable logic or circuitry that is temporarily configured by software to perform certain operations.
[0228] In addition, modules and components can be implemented as firmware or functional circuits within hardware devices. Further, modules and components can be implemented in any combination of hardware devices and software components, or only in software (e.g., code stored or otherwise embodied in a machine-readable medium or transmission medium).
[0229] Figure 8 A radiotherapy apparatus according to the invention is described. Figure 8 A cross section of a radiotherapy apparatus 800 is shown including a radiation head 804 and a beam receiving device 806, both of which are attached to a gantry 802. The radiation head 804 includes a radiation source 807 that emits a radiation beam 822. The radiation head 804 also includes a beam shaping device 850 that controls the size and shape of the radiation field associated with the beam.
[0230] The beam receiving device 806 is configured to receive radiation emitted from the radiation head 804 in order to absorb and / or measure the radiation beam. Figure 8 In the view shown, the radiation head 804 and the beam receiving device 806 are positioned diametrically opposite each other.
[0231] The gantry 802 is rotatable and supports the radiation head 804 and the beam receiving device 806 so that they can rotate about an axis of rotation 805, which can coincide with the longitudinal axis of the patient. Figure 8 As shown, the gantry provides rotation of the radiation head 804 and the beam receiving device 806 in a plane perpendicular to the longitudinal axis of the patient (e.g., the sagittal plane). Three gantry directions XG, YG, and ZG can be defined, wherein the YG direction is perpendicular to the gantry rotation axis. The ZG direction extends from a point on the gantry corresponding to the radiation head toward the gantry rotation axis. Therefore, from the patient reference system, the ZG direction rotates as the gantry rotates.
[0232] Figure 8 Also shown is a support surface 810 on which a subject (or patient) is supported during radiation therapy. The radiation head 804 is configured to rotate about a rotation axis 805 so that the radiation head 804 directs radiation to the subject from various angles around the subject so as to spread the radiation dose received by healthy tissue to a larger area of healthy tissue while accumulating a prescribed radiation dose at the target area.
[0233] The radiation therapy apparatus 800 is configured to deliver a radiation beam towards a radiation isocenter that is approximately located on a rotation axis 805 at the center of the gantry 802 , regardless of the angle at which the radiation head 804 is placed.
[0234] The rotatable gantry 802 and radiation head 804 are sized to allow for a central aperture 880. Central aperture 880 provides an opening sufficient to allow a subject to be positioned therethrough without being accidentally contacted by the radiation head 804 or other mechanical components as the gantry rotates the radiation head 804 about the subject.
[0235] like Figure 8 As shown, the radiation head 804 emits a radiation beam 822 along a beam axis 890 (or radiation axis or beam path), wherein the beam axis 890 is used to define the direction in which the radiation head emits radiation. The radiation beam 822 is incident on a beam receiving device 806, which may include at least one of a beam stopper and a radiation detector. The beam receiving device 806 is attached to the gantry 802 on a side diametrically opposite to the radiation head 804 to attenuate and / or detect the radiation beam after the beam passes through the subject.
[0236] For example, radiation beam axis 890 may be defined as the center or point of maximum intensity of radiation beam 822 .
[0237] The beam shaper 850 defines the spread of the radiation beam 822. The beam shaper 850 is configured to adjust the shape and / or size of the radiation field generated by the radiation source. The beam shaper 850 achieves this by defining a variable shaped aperture (also referred to as a window or opening) to calibrate the radiation beam 822 to a selected cross-sectional shape. In this example, the beam shaper 850 may be provided by a combination of an aperture and a multi-leaf collimator (MLC). The beam shaper 850 may also be referred to as a beam modifier.
[0238] The radiation therapy device 800 can be configured to perform radiation therapy in coplanar and non-coplanar (also called tilted) modes. In coplanar therapy, radiation is emitted in a plane that is perpendicular to the axis of rotation of the radiation head 804. In non-coplanar therapy, radiation is emitted at an angle that is not perpendicular to the axis of rotation. To perform coplanar and non-coplanar therapy, the radiation head 804 can be moved between at least two positions, one in which radiation is emitted in a plane that is perpendicular to the axis of rotation (coplanar configuration) and one in which radiation is emitted in a plane that is not perpendicular to the axis of rotation (non-coplanar configuration).
[0239] In a coplanar configuration, the radiation head is positioned to rotate about an axis of rotation and in a first plane. In a non-coplanar configuration, the radiation head is tilted relative to the first plane so that the radiation field generated by the radiation head is directed at an oblique angle relative to the first plane and the axis of rotation. In a non-coplanar configuration, the radiation head is positioned to rotate in a respective second plane parallel to and displaced from the first plane. The radiation beam is emitted at an oblique angle relative to the second plane so that the beam sweeps out a cone when the radiation head rotates.
[0240] When the radiotherapy apparatus is in coplanar mode and non-coplanar mode, the beam receiving device 806 remains in the same position relative to the rotatable gantry. Therefore, the beam receiving device 806 is configured to rotate about the rotation axis in the same plane in both coplanar mode and non-coplanar mode. This can be the same plane as the plane in which the radiation head rotates.
[0241] The beam shaping device 850 is configured to reduce the spread of the radiation field in a non-coplanar configuration compared to a coplanar configuration.
[0242] Radiation therapy apparatus 800 includes a controller 840 programmed to control radiation source 807, beam receiving device 806, and gantry 802. Controller 840 may perform functions or operations such as treatment planning, treatment delivery, image acquisition, image processing, motion tracking, motion management, and / or other tasks involved in a radiation therapy procedure.
[0243] The controller 840 is programmed to control features of the apparatus 800 in accordance with a radiation therapy plan in order to irradiate a target area of the patient, also referred to as target tissue. The treatment plan includes information about a specific dose to be applied to the target tissue as well as other parameters such as beam angles, dose histogram volume information, the number of radiation beams to be used during treatment, the dose of each beam, etc. The controller 840 is programmed to control various components of the apparatus 800, such as the gantry 802, the radiation head 804, the beam receiving device 806, and the support surface 810, in accordance with the treatment plan.
[0244] The hardware components of the controller 840 may include one or more computers (e.g., general-purpose computers, workstations, servers, terminals, portable / mobile devices, etc.); processors (e.g., central processing units (CPUs), graphics processing units (GPUs), microprocessors, digital signal processors (DSPs), field programmable gate arrays (FPGAs), dedicated or specially designed processors, etc.); memory / storage devices, such as memory (e.g., read-only memory (ROM), random access memory (RAM), flash memory, hard disk drives, optical disks, solid-state drives (SSDs), etc.); input devices (e.g., keyboards, mice, touch screens, MICS, buttons, knobs, trackballs, joysticks, handles, joysticks, etc.); output devices (e.g., displays, printers, speakers, vibration devices, etc.); circuits; printed circuit boards (PCBs); or other suitable hardware. The software components of the controller 840 may include operating device software, application software, etc.
[0245] The radiation head 804 may be connected to a head actuator 830 that is configured to actuate the radiation head 804, for example, between a coplanar configuration and one or more non-coplanar configurations. This may involve translation and rotation of the radiation head 804 relative to the gantry. In some implementations, the head actuator may include a curved track along which the radiation head 804 may move to adjust the position and angle of the radiation head 804. The controller 840 may control the configuration of the radiation head 804 via the head actuator 830.
[0246] The beam shaping device 850 includes a shaping actuator 832. The shaping actuator is configured to control the position of one or more elements in the beam shaping device 850 so as to shape the radiation beam 822. In some implementations, the beam shaping device 850 includes an MLC, and the shaping actuator 832 includes a means for actuating leaves of the MLC. The beam shaping device 850 may also include an aperture, and the shaping actuator 832 may include a means for actuating a block of the aperture. The controller 840 may control the beam shaping device 850 via the shaping actuator 832.
[0247] The treatment plan may include positioning information of the beam shaping device 850. The positioning information of the beam shaping device 850 may include information indicating the configuration of one or more elements of the beam shaping device 850, such as the configuration of leaves of the MLC of the beam shaping device 850, the configuration of the aperture of the beam shaping device 850, the configuration of an opening (e.g., a window or aperture) of the MLC, etc.
[0248] Additional Notes
[0249] As described herein, the goal of the optimizer (or optimization process) is to find an optimized parameter set that minimizes the cost function. However, it will be understood that alternatively and equivalently, the goal of the optimizer (or optimization process) can be to find an optimized parameter set that maximizes the reward function.
[0250] As described herein, a dose volume metric includes a dose value and a corresponding volume value. The dose value and the corresponding volume value can be obtained from a dose distribution to be achieved in the anatomical structure. The dose volume metric of the anatomical structure indicates how much (i.e., what volume) of the anatomical structure receives a specific dose. The dose volume metric can be a specific dose to be received by a specific volume of the anatomical structure. More particularly, as described above, the dose volume metric can be (i) the dose to be received by a prescribed volume of the anatomical structure (the achieved dose under the reference volume), and / or (ii) the volume of the anatomical structure that will actually receive the prescribed dose (the achieved volume under the reference dose). It will be understood that, alternatively, the dose volume metric can be (a) the dose to be received by a volume between 70% and 100% of the prescribed volume of the anatomical structure (the achieved dose under the volume of 70%-100% of the reference volume), and / or (b) the volume of the anatomical structure that will receive a dose of 80% to 120% of the prescribed dose (the achieved volume under the dose of 80%-120% of the reference dose). In other examples, the dose volume metric may be the dose to be received by a volume between 80% and 100% or between 90% and 100% of a prescribed volume of the anatomy, and / or the volume of the anatomy to receive a dose between 90% and 110% of the prescribed dose.
[0251] Unless specifically stated otherwise, as will be apparent from the following discussion, it should be understood that throughout the specification, discussions utilizing terms such as "receiving," "determining," "comparing," "implementing," "maintaining," "identifying," "obtaining," "accessing," etc. refer to the actions and processes of a computer system or similar electronic computing device that manipulates data represented as physical (electronic) quantities within the computer system's registers and memories and transforms it into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission, or display devices.
[0252] Although certain embodiments have been described, these embodiments are presented by way of example only and are not intended to limit the scope of the invention. In fact, the novel methods and devices described herein can be embodied in various other forms; in addition, various omissions, substitutions, and changes can be made to the forms of the methods and devices described herein.
[0253] Example
[0254] Aspects and features of the invention are set out in the following numbered clauses.
[0255] Clause 1. A method for radiotherapy planning for a radiotherapy system, the method comprising:
[0256] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system, and the first reference target comprising a reference dose to be delivered to a reference volume of the anatomical structure;
[0257] Optimizing a set of parameters related to characteristics of radiation to be delivered by the radiotherapy system based on the received first reference target and the received second reference target, wherein the optimized set of parameters comprises:
[0258] optimizing the set of parameters based on the first reference objective to obtain a dose-volume metric for the anatomical structure; and
[0259] further optimizing the set of parameters based on a second reference objective using the dose volume metric as a constraint; and
[0260] A radiation therapy plan was generated using the further optimized parameter sets.
[0261] Clause 2. The method of clause 1, wherein the dose volume metric comprises an achieved dose at a volume between 70% and 100% of a reference volume and / or an achieved volume at a dose between 80% and 120% of the reference dose.
[0262] Clause 3. The method of clause 1 or 2, wherein the dose volume metric comprises an achieved dose at a reference volume and / or an achieved volume at a reference dose.
[0263] Clause 4. The method according to any of the preceding clauses, wherein the optimization parameter set comprises:
[0264] In response to the dose-volume metric not satisfying the first reference objective, the parameter set is further optimized based on a second reference objective using the dose-volume metric as a constraint.
[0265] Clause 5. The method of clause 4, when dependent on clause 3, wherein the set of optimization parameters comprises:
[0266] In response to the achieved dose at the reference volume and / or the achieved volume at the reference dose not satisfying the first reference target, modifying the achieved dose at the reference volume to obtain a relaxation dose; and
[0267] The parameter set is further optimized based on the second reference target using the relaxation dose at the reference volume as a constraint.
[0268] Clause 6. The method of any preceding clause, wherein obtaining a dose volume metric from the optimized parameter set comprises:
[0269] obtaining a dose distribution in the anatomical structure using the optimized parameter set; and
[0270] Dose volume metrics are obtained from the dose distribution.
[0271] Clause 7. The method of clause 6, wherein the dose distribution is represented by a dose volume histogram (DVH).
[0272] Clause 8. The method of any of the preceding clauses, wherein the first reference target comprises any of the following cost functions: a target penalty cost function; an underdose DVH cost function, an overdose DVH cost function, and a parallel cost function.
[0273] Clause 9. The method of clause 8, wherein the constraint used in the further optimization comprises the same cost function as the first reference objective.
[0274] Clause 10. The method according to any of the preceding clauses, wherein the optimization parameter set comprises:
[0275] optimizing the set of parameters based on the first reference objective to obtain a dose-volume metric; and
[0276] further optimizing the parameter set using the dose-volume metric as a target to obtain an intermediate parameter set;
[0277] The intermediate parameter set is further optimized based on the second reference target and using the dose volume metric as a constraint to obtain a further optimized parameter set.
[0278] Clause 11. A method according to clause 10, wherein the dose-volume metric includes an achieved volume at a reference dose and / or an achieved dose at a reference volume, and wherein further optimizing the parameter set using the dose-volume metric as a target includes using a weighted sum of a first cost function based on the achieved volume at the reference dose and a second cost function based on the achieved dose at the reference volume.
[0279] Clause 12. A method for radiation therapy planning for a radiation therapy system, the method comprising:
[0280] receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system, the reference target comprising a reference dose to be delivered to a reference volume of the anatomical structure;
[0281] Optimizing a set of parameters according to the received reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein the optimized set of parameters comprises:
[0282] optimizing a set of parameters based on a reference target to obtain a dose-volume metric; and
[0283] further optimizing the parameter set based on the received reference target and an additional target based on the dose-volume metric;
[0284] A radiation therapy plan was generated using the further optimized parameter sets.
[0285] Clause 13. The method of Clause 12, wherein the dose volume metric comprises an achieved volume at a reference dose and / or an achieved dose at a reference volume.
[0286] Clause 14. The method of clause 12 or 13, wherein further optimizing the set of parameters comprises using a cost function based on a weighted sum of the reference objective and the further objective.
[0287] Clause 15. A computer-readable medium comprising computer-executable instructions configured to cause a processor to perform any of the preceding clauses.
[0288] Clause 16. A radiation therapy planning system comprising a processor configured to:
[0289] receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system, and the first reference target comprising a reference dose to be delivered to a reference volume of the anatomical structure;
[0290] Optimizing a set of parameters related to characteristics of radiation to be delivered by the radiotherapy system based on the received first reference target and the received second reference target, wherein the optimized set of parameters comprises:
[0291] optimizing the set of parameters based on the first reference objective to obtain a dose-volume metric; and
[0292] further optimizing the parameter set based on a second reference objective using the dose-volume metric as a constraint;
[0293] A radiation therapy plan was generated using the further optimized parameter sets.
[0294] Clause 17. The treatment planning system of clause 16, wherein the processor is configured to perform any of the above methods.
[0295] Clause 18. A radiation therapy planning system comprising a processor configured to:
[0296] receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system, the reference target comprising a reference dose to be delivered to a reference volume of the anatomical structure;
[0297] Optimizing a set of parameters according to the received reference target, the set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system, wherein the optimized set of parameters comprises:
[0298] optimizing a set of parameters based on a reference target to obtain a dose-volume metric; and
[0299] further optimizing the parameter set based on the received reference target and an additional target based on the dose-volume metric;
[0300] A radiation therapy plan was generated using the further optimized parameter sets.
[0301] Clause 19. The treatment planning system of Clause 18, wherein the processor is configured to perform any of the above methods.
Claims
1. A method for radiotherapy planning for a radiotherapy system, the method comprising: receiving a first reference target and a second reference target, each reference target representing a target to be achieved by the radiation therapy system, the first reference target comprising a reference dose to be delivered to a reference volume of an anatomical structure; Optimizing a set of parameters related to characteristics of radiation to be delivered by the radiotherapy system based on the received first reference target and the received second reference target, wherein optimizing the set of parameters comprises: optimizing the set of parameters based on the first reference target to obtain a dose-volume metric for the anatomical structure; and further optimizing the set of parameters based on the second reference objective using the dose volume metric as a constraint; and A radiation therapy plan was generated using the further optimized parameter sets.
2. The method according to claim 1, characterized in that The dose volume metric includes an achieved dose at a volume between 70% and 100% of the reference volume and / or an achieved volume at a dose between 80% and 120% of the reference dose.
3. The method according to claim 1, characterized in that The dose-volume metric comprises an achieved dose at the reference volume and / or an achieved volume at the reference dose.
4. The method according to claim 1, characterized in that: Optimizing the parameter set includes: In response to the dose-volume metric not satisfying the first reference objective, further optimizing the set of parameters based on the second reference objective using the dose-volume metric as a constraint.
5. The method according to claim 3, characterized in that: Optimizing the parameter set includes: in response to the achieved dose at the reference volume and / or the achieved volume at the reference dose not satisfying the first reference target, modifying the achieved dose at the reference volume to obtain a relaxation dose; and The parameter set is further optimized based on the second reference target using the relaxation dose at the reference volume as a constraint.
6. The method according to claim 1, characterized in that Obtaining the dose volume metric from the optimized set of parameters comprises: obtaining a dose distribution in the anatomical structure using the optimized set of parameters; and The dose volume metric is obtained from the dose distribution.
7. The method according to claim 6, characterized in that The dose distribution is represented by a dose volume histogram (DVH).
8. The method according to claim 1, characterized in that: The first reference target includes any of the following cost functions: a target penalty cost function; Underdose Dose Volume Histogram (DVH) cost function, Overdose DVH cost function and Parallel cost function.
9. The method according to claim 8, characterized in that The constraints used in the further optimization include the same cost function as the first reference objective.
10. The method according to claim 1, characterized in that Optimizing the parameter set includes: optimizing the set of parameters based on the first reference target to obtain the dose volume metric; further optimizing the set of parameters using the dose volume metric as a target to obtain an intermediate set of parameters; and The intermediate parameter set is further optimized based on the second reference target and using the dose volume metric as a constraint to obtain the further optimized parameter set.
11. The method according to claim 10, characterized in that The dose-volume metric comprises an achieved volume at the reference dose and / or an achieved dose at the reference volume, and further optimizing the parameter set using the dose-volume metric as a target comprises using a weighted sum of a first cost function based on the achieved volume at the reference dose and a second cost function based on the achieved dose at the reference volume.
12. A method for radiotherapy planning for a radiotherapy system, the method comprising: receiving a reference target, the reference target representing a target to be achieved by the radiation therapy system, the reference target comprising a reference dose to be delivered to a reference volume of an anatomical structure; Optimizing a set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system according to the received reference target, wherein optimizing the set of parameters comprises: optimizing the set of parameters based on the reference target to obtain a dose volume metric; and further optimizing the set of parameters based on the received reference target and a further target based on the dose volume metric; and A radiation therapy plan was generated using the further optimized parameter sets.
13. The method according to claim 12, characterized in that The dose-volume metric comprises an achieved volume at the reference dose and / or an achieved dose at the reference volume.
14. The method according to claim 12, characterized in that Further optimizing the set of parameters comprises using a cost function based on a weighted sum of the reference objective and the further objective.
15. A non-transitory computer-readable medium comprising computer-executable instructions configured to cause a processor to: receiving a first reference target and a second reference target, each reference target representing a target to be achieved by a radiation therapy system, and the first reference target comprising a reference dose to be delivered to a reference volume of an anatomical structure; A set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system is optimized based on the received first reference target and the received second reference target, wherein, Optimizing the parameter set includes: optimizing the set of parameters based on the first reference target to obtain a dose volume metric; and further optimizing the set of parameters based on the second reference objective using the dose volume metric as a constraint; and A radiation therapy plan was generated using the further optimized parameter sets.
16. A radiation therapy planning system, comprising a processor, wherein the processor is configured to: receiving a first reference target and a second reference target, each reference target representing a target to be achieved by a radiation therapy system, and the first reference target comprising a reference dose to be delivered to a reference volume of an anatomical structure; A set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system is optimized based on the received first reference target and the received second reference target, wherein, Optimizing the parameter set includes: optimizing the set of parameters based on the first reference target to obtain a dose volume metric; and further optimizing the set of parameters based on the second reference objective using the dose volume metric as a constraint; and A radiation therapy plan was generated using the further optimized parameter sets.
17. A radiation therapy planning system, comprising a processor, the processor being configured to: receiving a reference target, the reference target representing a goal to be achieved by the radiation therapy system, the reference target comprising a reference dose to be delivered to a reference volume of the anatomical structure; A set of parameters relating to characteristics of radiation to be delivered by the radiotherapy system is optimized according to the received reference target, wherein Optimizing the parameter set includes: optimizing the set of parameters based on the reference target to obtain a dose volume metric; and further optimizing the set of parameters based on the received reference target and a further target based on the dose volume metric; and A radiation therapy plan was generated using the further optimized parameter sets.
